CLAL BIOTECHNOLOGY INDUSTRIES
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)
CLAL BIOTECHNOLOGY INDUSTRIES
Social Links:
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
1998-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Domain Not Resolving
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Reaction Biology
Reaction Biology is an industry leader and innovator specializing in assay services and protein production for early-stage drug discovery
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Current Advisors List
Current Employees Featured
Stock Details
Company's stock symbol is TLV:CBI
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-08-05 | Sight Diagnostics | Clal Biotechnology Industries investment in Series D - Sight Diagnostics | 71 M USD |
| 2020-04-29 | Cadent Therapeutics | Clal Biotechnology Industries investment in Series B - Cadent Therapeutics | 15 M USD |
| 2019-10-02 | Elicio Therapeutics | Clal Biotechnology Industries investment in Series B - Elicio Therapeutics | 33 M USD |
| 2018-04-13 | Anchiano Therapeutics | Clal Biotechnology Industries investment in Post-IPO Equity - Anchiano Therapeutics | 23 M USD |
| 2017-10-01 | Colospan | Clal Biotechnology Industries investment in Venture Round - Colospan | 8 M USD |
| 2017-06-19 | Gamida Cell | Clal Biotechnology Industries investment in Series F - Gamida Cell | 40 M USD |
| 2016-01-07 | Pi-Cardia | Clal Biotechnology Industries investment in Series C - Pi-Cardia | 10 M USD |
| 2015-10-01 | Neon Therapeutics | Clal Biotechnology Industries investment in Series A - Neon Therapeutics | 55 M USD |
| 2014-11-01 | Sight Diagnostics | Clal Biotechnology Industries investment in Series A - Sight Diagnostics | 6 M USD |
| 2013-09-17 | CureTech | Clal Biotechnology Industries investment in Venture Round - CureTech | 4 M USD |